Johnson & Johnson today announced positive topline results from the Phase 2b JASMINE (NCT04882878) study of adults living with systemic lupus erythematosus (SLE) and the initiation of a Phase 3 ...
Pathophysiologic biomarkers for chronic spontaneous urticaria (CSU) are emerging, which can help better target therapies for the potentially debilitating condition.
Atherosclerosis is a lipid-driven chronic inflammatory disease that is modulated by innate and adaptive immunity including humoral immunity. Importantly, antibody alterations achieved by genetic means ...
Ash Hewson is CEO of Affinity, part of Canva. When I announced at Canva World Tour in October that the all-new, professional-grade Affinity would become completely free, the design world reacted with ...
Affinity Partners, Mr. Kushner’s private equity firm, played a small financial role in Paramount’s $108 billion offer, but it had attracted political attention to the deal. By Lauren Hirsch Jared ...
(Bloomberg) --Jared Kushner’s Affinity Partners is exiting the takeover battle for Warner Bros. Discovery Inc. in a political and financial blow to a foundering hostile takeover bid for the fabled ...
Journalist Jo Ling Kent joined CBS News in July 2023 as the senior business and technology correspondent for CBS News. Kent has more than 15 years of experience covering the intersection of technology ...
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
Jared Kushner's private equity firm says it is dropping out of the group of firms that planned to back Paramount Skydance's hostile takeover bid for Warner Bros. Discovery. "With two strong ...
Background Hepatocellular carcinoma (HCC) is a leading cause of cancer mortality with limited therapeutic options. Despite ...
IGY Life Sciences has optimized the sustainable generation of highly specific and efficacious egg-derived IgY antibodies for human and animal health. The company’s pipeline includes marketed immune ...